Showing results (911-920 of 2,640) with videos related to

Sort By:
Pageof 264
Oncology Research|January 1, 1994
Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cellsM Fanciulli, M G Paggi, T Bruno, et al.
Oncology Research|January 1, 1994
Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreasS P Povoski, W Zhou, D S Longnecker, et al.
Oncology Research|January 1, 1994
Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variantsC Sonnenschein, J Szelei, T L Nye, et al.
Oncology Research|January 1, 1994
p53 mutations in bladder carcinoma cell linesM J Cooper, J J Haluschak, D Johnson, et al.
Oncology Research|January 1, 1994
Whole-body autoradiographic study of [3H]-PK 11195 distribution in dunning AT-1 tumour-bearing ratsJ Alenfall, R d'Argy, S Batra
Oncology Research|January 1, 1997
Variations in the expression of the adenomatous polyposis coli (APC) tumor suppressor gene in human cancer cell lines of different tissue originS Dihlmann, L C Amler, M Schwab, et al.
Oncology Research|January 1, 1997
Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell linesJ J McGuire, K J Magee, C A Russell, et al.
Oncology Research|January 1, 1992
Pharmacodynamic and pharmacokinetic aspects of iodo-doxorubicinK Mross, U Mayer, W Zeller, et al.
Oncology Research|January 1, 1993
Inhibition of fibroblast hyaluronic acid production by suraminE M August, K L Duncan, N M Malinowski, et al.
Oncology Research|January 1, 1993
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenograftsR M Schultz, R L Merriman, J E Toth, et al.
Pageof 264